Literature DB >> 25755895

Second-degree interatrial block in hemodialysis patients.

Andres Enriquez1, Marco Marano2, Anna D'Amato2, Antoni Bayes de Luna3, Adrian Baranchuk1.   

Abstract

Interatrial conduction delays manifest as a prolonged P-wave duration on surface ECG and the term interatrial block (IAB) has been coined. They are usually fixed, but cases of intermittent IAB have been described, suggesting functional conduction block at the Bachmann bundle region. We report 2 cases of patients on chronic hemodialysis therapy presenting with intermittent IAB.

Entities:  

Year:  2015        PMID: 25755895      PMCID: PMC4338407          DOI: 10.1155/2015/468493

Source DB:  PubMed          Journal:  Case Rep Cardiol        ISSN: 2090-6404


1. Introduction

Interatrial block (IAB), defined as a conduction delay between the right and left atrium, is manifested on the electrocardiogram (ECG) as a prolonged P-wave duration and can be classified as partial (P-wave ≥ 120 ms) or advanced (P-wave ≥ 120 with biphasic [±] morphology in the inferior leads) [1]. However, IAB may also be intermittent [2] and the term “second-degree IAB” has been proposed [1]. We report 2 cases of patients on chronic hemodialysis therapy presenting with second-degree IAB.

2. Patient 1

First case is an 81-year-old female with end-stage renal disease of unknown etiology who presented to her hemodialysis session complaining of weakness and nausea. No prior history of atrial fibrillation (AF) was present. The previous day, after taking 50 mg of tramadol at bedtime for bone pain, she experienced malaise and vomiting. At the hemodialysis unit next morning, she was still feeling nauseous. Her blood pressure was low (90/60 mmHg) and interdialytic weight gain was only 0.8 Kg. An ECG recorded in the context of vomiting showed a prolonged P-wave (120 ms) with a prominent negative terminal component in the inferior leads, compatible with a pattern of advanced IAB (Figure 1(b)). In contrast, a resting ECG performed 1 month earlier had shown sinus rhythm with normal P-wave duration and PR interval (Figure 1(a)). The similar P-wave morphology in lead V1 suggests that both tracings correspond to sinus rhythm rather than an ectopic rhythm. Blood gas analysis revealed normal acid-base status and electrolytes. Predialysis serum total concentration of calcium was 9.4 mg/dL and of potassium was 4.8 mEq/L. Predialysis blood gas analysis showed ionized calcium of 1.14 mmol/L and potassium of 4.4 mmol/L. Bicarbonate-dialysis was performed. The session was uneventful, with 1 L fluid removal. Potassium and calcium dialysate concentration were 3.0 mEq/L and 1.5 mEq/L, respectively. Two days later, a repeated ECG showed resolution of the advanced IAB (Figure 1(c)).
Figure 1

(a) 4-lead ECG 1 month prior to the episode. Normal P-wave. (b) 4-lead ECG during the episode. Note advanced IAB without changes in lead V1, confirming this is not an ectopic rhythm. (c) 4-lead ECG after the episode. Changes have disappeared.

3. Patient 2

Second case is an 86-year-old lady with hypertensive end-stage renal disease who had been on hemodialysis therapy in our center since 2006. Her past medical story was significant for long-standing hypertension (40-year duration), ischemic heart disease with myocardial infarctions in 2006 and 2012, a transient ischemic attack in 2012, osteoporosis with low-normal parathyroid hormone (adynamic bone disease), and no prior history of AF. Her medications list included Clopidogrel 75 mg, Atorvastatin 40 mg, Bisoprolol 2.5 mg, Amlodipine 10 mg, Omeprazole 20 mg, and Epoetin 4000 units. During a routine hemodialysis session she referred to mild dyspepsia. Predialysis serum total concentration of calcium was 8.4 mg/dL and of potassium was 5.7 mEq/L. Predialysis blood gas analysis showed ionized calcium of 1.06 mmol/L and potassium of 5.1 mmol/L. The dialysis was 240 minutes' duration, with 1.8 L fluid removal, bicarbonate 35.0 mmol/L, K 3.0 mmol/L, and Ca 1.5 mmol/L. Soon after dialysis treatment, she complained of heartburn, bloating, nausea, and vomiting. Blood pressure, arterial blood gas analysis, and amylase levels were all normal. A 12-lead ECG showed partial IAB (P-wave 130 ms), with transient development of a terminal negative component in the inferior leads, which resolved after a few beats without significant change in heart rate (leads I, II, and III shown in Figure 2).
Figure 2

Continuous ECG tracing (leads I, II, and III), showing a prolonged P-wave duration, with transient development of a negative component in II and III (arrow), which resolves after 7 beats (asterisk).

IAB is a prevalent condition, especially in patients with structural heart disease, and is frequently associated with atrial arrhythmias, such as AF and flutter [3-6]. This association is particularly strong for patients with advanced IAB. This electrocardiographic pattern is consequence of marked conduction delay at the Bachman region and retrograde (caudocranial) activation of the left atrium mainly through the coronary sinus, which explains the negative terminal deflection of the P-wave in II, III, and aVF [7, 8]. Advanced IAB leads to heterogeneous electrical activation, dispersion of refractoriness, and left atrial mechanical dysfunction, all factors that predispose to the genesis of atrial arrhythmias [9]. The present cases show that, similarly to conduction blocks at the level of the atrioventricular junction, sinoatrial junction, or the ventricles, IAB may occur transiently and intermittently. Intermittent IAB can occur with every other sinus beats or without a recognizable pattern and the mechanism is unclear. The most likely explanation is a functional block in one or more of the specialized interatrial tracts [2]. Positional changes of the atria can be postulated, but this is unlikely since previous reports have shown that patients with intermittent IAB may develop fixed IAB over time [2]. Transient IAB has also been described in the context of decompensated heart failure, which has been attributed to atrial strain and is reverted to by diuretic therapy [10]. The 2 cases presented here were observed in the context of emesis. It is possible that some degree of autonomic or acute electrolytic disturbance may play a role in the development of functional block.
  10 in total

1.  Association of interatrial block with development of atrial fibrillation.

Authors:  Yogesh K Agarwal; Wilbert S Aronow; James A Levy; David H Spodick
Journal:  Am J Cardiol       Date:  2003-04-01       Impact factor: 2.778

2.  Dynamic variations of P-wave duration in a patient with acute decompensated congestive heart failure.

Authors:  Riccardo Proietti; Antonio Mafrici; David H Spodick
Journal:  Cardiol J       Date:  2012       Impact factor: 2.737

3.  Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion.

Authors:  Andres Enriquez; Diego Conde; Wilma Hopman; Ignacio Mondragon; Pablo A Chiale; Antoni Bayés de Luna; Adrian Baranchuk
Journal:  Cardiovasc Ther       Date:  2014-04       Impact factor: 3.023

4.  Intermittent intra-atrial block: its diagnosis, incidence and implications.

Authors:  M J Legato; M I Ferrer
Journal:  Chest       Date:  1974-03       Impact factor: 9.410

5.  Electromechanical dysfunction of the left atrium associated with interatrial block.

Authors:  S B Goyal; D H Spodick
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

6.  Atrial activation mapping in sinus rhythm in the clinical electrophysiology laboratory: observations during Bachmann's bundle block.

Authors:  Francisco G Cosío; Arturo Martín-Peñato; Agustín Pastor; Ambrosio Núñez; María Antonia Montero; Carina P Cantale; Salomao Schames
Journal:  J Cardiovasc Electrophysiol       Date:  2004-05

7.  Interatrial blocks. A separate entity from left atrial enlargement: a consensus report.

Authors:  Antonio Bayés de Luna; Pyotr Platonov; Francisco G Cosio; Iwona Cygankiewicz; Carlos Pastore; Rafa Baranowski; Antoni Bayés-Genis; Josep Guindo; Xavier Viñolas; Javier Garcia-Niebla; Raimundo Barbosa; Shlomo Stern; David Spodick
Journal:  J Electrocardiol       Date:  2012-09       Impact factor: 1.438

8.  Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia.

Authors:  A Bayés de Luna; M Cladellas; R Oter; P Torner; J Guindo; V Martí; I Rivera; P Iturralde
Journal:  Eur Heart J       Date:  1988-10       Impact factor: 29.983

9.  Prolonged P-wave duration is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation.

Authors:  Jane Caldwell; Sahil Koppikar; Walid Barake; Damian Redfearn; Kevin Michael; Christopher Simpson; Wilma Hopman; Adrian Baranchuk
Journal:  J Interv Card Electrophysiol       Date:  2013-12-04       Impact factor: 1.900

10.  Relation of interatrial block to new-onset atrial fibrillation in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators.

Authors:  Andres Enriquez; Diego Conde; Francisco Femenia; Antoni Bayés de Luna; Antonio Ribeiro; Claudio Muratore; Mariana Valentino; Enrique Retyk; Nestor Galizio; Wilma M Hopman; Adrian Baranchuk
Journal:  Am J Cardiol       Date:  2014-03-02       Impact factor: 2.778

  10 in total
  4 in total

1.  The P-wave morphology: what does it tell us?

Authors:  Adrian Baranchuk; Antoni Bayés de Luna
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-09

Review 2.  Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance.

Authors:  Nicolas Johner; Mehdi Namdar; Dipen C Shah
Journal:  J Interv Card Electrophysiol       Date:  2018-08-20       Impact factor: 1.900

Review 3.  Second-degree interatrial block: Brief review and concept.

Authors:  Antonio Bayés de Luna; Adrián Baranchuk; César Niño Pulido; Manuel Martínez-Sellés; Antonio Bayés-Genís; Roberto Elosua; Marcelo V Elizari
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-02       Impact factor: 1.468

Review 4.  Electrophysiological Mechanisms of Bayés Syndrome: Insights from Clinical and Mouse Studies.

Authors:  Gary Tse; Eric Tsz Him Lai; Jie Ming Yeo; Bryan P Yan
Journal:  Front Physiol       Date:  2016-05-31       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.